(Total Views: 350)
Posted On: 09/23/2019 9:50:44 AM
Post# of 92
$AVDL News Article - Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019 https://marketwirenews.com/news-releases/avad...00728.html
(0)
(0)
My Twitter: WhyteStocks
